We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App

Mindray Demonstrates All In One Hematology Solution Designed for Enhanced Testing Efficiency

By LabMedica International staff writers
Posted on 21 May 2023
Print article
Image: Mindray’s total laboratory solutions ensure greater efficiency (Photo courtesy of Mindray)
Image: Mindray’s total laboratory solutions ensure greater efficiency (Photo courtesy of Mindray)

Mindray (Shenzhen, China) is demonstrating its latest technologies and solutions in in-vitro diagnostics at WorldLab–EuroMedLab Roma 2023, including the company’s ALL IN ONE hematology solution that brings greater efficiency to hematology testing with simplified workflows and ease of operation.

Mindray's ALL IN ONE Hematology Solution enables end-to-end automation throughout the process, from tube sorting through to analysis of CBC, ESR, CRP, SAA, and HbA1c with a single EDTA tube, smear preparation, and slide reading. The solution is ideal for core or centralized laboratories with mid-to-high sample volumes and high demand for turnaround times. Mindray's ALL IN ONE Hematology Solution comprises the H50 HPLC analyzer for HbA1c analysis, MC-80 digital morphology analyzer for slide reading, SC-120 auto slide maker & stainer for smear preparation, BP-200n ESR & SAA analyzer for ESR + SAA analysis, BC-6800Plus auto hematology analyzer for accurate & reliable analysis by 3D SF-Cube with auto re-analysis, and TM-1000 tube sorter for sorting & storage.

Among other innovative products being showcased at Mindray’s booth is the CAL 8000 New Generation Cellular Analysis Line which marks Mindray's expertise and innovative power in the hematology area for large-scale laboratories. It has higher throughput per square meter, upgraded labXpert Data Management Software, flexible layout design options, and other advanced functionalities. Combining Mindray’s new MC-80 Digital Cell Morphology Analyzer, the CAL 8000 takes hematology analysis automation to the next level.

Also featuring at the event is Mindray’s M1000 integrated chemistry and immunoassay system which is specially designed for large-scale laboratories. It supports loading up to 580 samples continuously at one time and automatic sample tube decapping. The M1000 comes with innovative technologies, such as 360-degree sample barcode scanning, PDR optical platform, HIL.L SI solution, timely environment pressure, and CO2 monitoring, VU-Mix and FS-sampling, and whole blood HbA1c with auto sample increment tests. All these technologies help deliver high working efficiency and deliver high-quality patient reports in a short turn-around time (TAT).

Related Links:

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article


Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more


view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.